24th May 2016 06:49
LONDON (Alliance News) - Vectura Group PLC Tuesday said it has teamed up with Propeller Health to develop inhalers that will combine the pair's technology.
The London-listed respiratory pharmaceutical company plans to develop inhalers that use its proven dry powder inhaler technology with Propeller Health's digital health platform which has already been cleared by the US Food & Drug Administration.
Propeller provides the leading digital health platform for asthma and chronic obstructive pulmonary disease.
The initial focus of the collaboration will be the development of an add-on sensor for Vectura's lever-operated multi-dose inhaler. Vectura said patients that have a lever-operated multi-dose inhaler that is connected to Propeller's platform will be "more engaged with their care and better equipped to understand their disease".
The companies are also discussing additional connected strategies for other proprietary respiratory devices in Vectura's pipeline.
"Adherence to therapy is one of the major issues driving poor maintenance management of these chronic conditions. There is increasing evidence of the value of intelligent sensor technology significantly enabling a reduction of symptoms, including exacerbations and long term healthcare utilisation costs. This collaboration is a first step towards Vectura embracing a connected solution for all our devices," said Vectura Chief Executive James Ward-Lilley.
By Joshua Warner; [email protected]; @JoshAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
VEC.L